Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501730 · ClinicalTrials.gov registry record
Use of the Quantra QPlus Sytem in Cardiac Surgery
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 128
- Enrollment target
NCT05501730: Completed study, sponsored by HemoSonics.
NCT05501730 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05501730 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Primary Outcome
Units of blood products administered to patient
Interventions
- DIAGNOSTIC_TEST Quantra QPlus System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2021-12-15 |
What the finished NCT05501730 record still lists
NCT05501730 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quantra QPlus System is the first listed.
NCT05501730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05501730 about?
NCT05501730 is a clinical study titled "Use of the Quantra QPlus Sytem in Cardiac Surgery". Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
What is the current status of trial NCT05501730?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2021-06-15. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT05501730?
The interventions under investigation include: Quantra QPlus System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05501730?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI